ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 428

TNFα Modulates the Expression of Circadian Clock Gene, Per2, Via D-Box Motif in the Promoter Region in Rheumatoid Synovial Cells

Kohsuke Yoshida1, Akira Hashiramoto2, Takaichi Okano3, Nao Shibanuma4 and Shunichi Shiozawa5, 1Hyogo Prefectural Rehabilitation Center at Nishi-harima, Tatsuno, Japan, 2Department of Internal Medicine, Kobe University Graduate School of Medicine / The Center for Rheumatic Diseases, Kobe University Hospital, Kobe, Japan, 3The Center for Rheumatic Diseases,, Kobe University Hospital, Kobe, Japan, 4The Center for Rheumatic Diseases, Kobe University Hospital / Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 5Department of Medicine, Kyushu University Beppu Hospital, Beppu, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA), synovial cells, synovial fluid and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The mammalian clock genes including Clock (circadian locomotor output cycles kaput), Bmal1 (brain and muscle Arnt-like protein 1), Per (Period) and Cry (Cryptochrome) regulate the circadian rhythm. We previously showed that arthritis was significantly accelerated in Cry1-/-Cry2-/- mice due to the activation of TNFα (tumor necrosis factor α) transcription, and TNFα inhibited the expression of Per2 mRNA in primary cultured human rheumatoid synovial cells. Here, we tried to elucidate the effects of TNFα on the transcription of Per2 gene in rheumatoid synovial cells.

Methods: Primary cultured rheumatoid synovial cells were synchronized upon incubation with 50% horse serum for 2 hours, and then stimulated with 10 ng/ml TNFα. Total RNA was extracted from synovial cells every 8 hrs until 32 hrs’ culture period, and mRNA expression of D-box binding protein genes, including Dbp (D site of albumin promoter binding protein), Hlf (hepatic leukemia factor), Tef (thyrotroph embryonic factor) and E4BP4  (E4-binding protein 4), were analyzed by real-time PCR. Synovial cells were transfected with the luciferase reporter vector containing the human Per2 promoter to measure the transcriptional activity of Per2 gene.

Results: The expression of Dbp, Hlf, and Tef mRNA were significantly inhibited (P <0.01), while those of E4bp4 mRNA was significantly increased (P <0.01) upon incubation with TNFα in rheumatoid synovial cells. Since Dbp, Hlf, Tef and E4bp4 genes could transactivate and suppress the expression of Per2 gene, respectively, by binding to D-box motif in the promoter region, we next introduced site-directed mutations into the D-box 1 (TTATGTAA, -372 to -365) and/or D-box 2 (TTACGTAA, -47 to -40) motif in the promoter, and then transfected rheumatoid synovial cells with luciferase reporter gene constructs driven by the Per2 promoter. As results, TNFα inhibited the transcriptional activity of the wild type of Per2 gene. However, when the promoter containing a mutated both D-box 1 and D-box 2 motif was transfected, TNFα-mediated transcriptional inhibition did not observed as compared with the wild type and the D-box 1 mutated promoter (P <0.05 and P<0.05, respectively).

Conclusion: TNFα significantly modulates the expression of Per2 gene via D-box binding protein, DBP, HLF, TEF and E4BP4, in rheumatoid synovial cells, and thereby may contribute to the pathogenesis of RA.


Disclosure:

K. Yoshida,
None;

A. Hashiramoto,
None;

T. Okano,
None;

N. Shibanuma,
None;

S. Shiozawa,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tnf%ce%b1-modulates-the-expression-of-circadian-clock-gene-per2-via-d-box-motif-in-the-promoter-region-in-rheumatoid-synovial-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology